Vitamin D3 (Cholecalciferol)Tablets/Capsules Suppliers & Bulk Manufacturers
Available Forms: Tablets/ Capsules
Available Strengths: 1000 IU, 2000 IU, 5000 IU, and 50,000 IU
Reference Brands: Nature’s Way, Kirkland, NOW Foods(US); Centrum, Solgar, Vitabiotics, and generics(EU)
Category:
Nutraceuticals
Vitamin D3 (Cholecalciferol) enhances calcium absorption in the gut, supporting bone health and immune function. It regulates calcium and phosphorus levels, preventing rickets and osteomalacia. Benefits include improved bone density, immune boost, reduced fall and fracture risk, and overall health support in deficiency conditions worldwide.
Vitamin D3 (Cholecalciferol)tablets/Capsules is available in Tablets/ Capsules
and strengths such as 1000 IU, 2000 IU, 5000 IU, and 50,000 IU.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Vitamin D3 (Cholecalciferol)tablets/Capsules is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Vitamin D3 (Cholecalciferol)tablets/Capsules can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Vitamin D3 (Cholecalciferol) tablets and capsules, marketed as Centrum, Solgar, and generic brands, are approved in the US by the FDA and in the EU via EMA for dietary supplementation and maintaining bone health. Regulatory approval requires comprehensive dossiers including ingredient safety, manufacturing standards, clinical efficacy, and pharmacovigilance plans. The FDA reviews clinical trial and safety data, while the EMA ensures regional safety and quality compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports timely approval, safe administration, and worldwide availability, helping promote optimal bone, immune, and overall health in populations globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing